ribociclib
novartis
['breast']
potentially a new standard of treatment in early stage er + her-2 negative breast cancer #asco23 
Prof. & Chair Dept. of Heme & Oncology @CleClinicMD @ClevelandClinic @NRGonc Deputy Editor @JCOOP_ASCO Tweets are mine. No act of #Kindness is ever wasted!